Insulet Corp (PODD) stock
PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3046% below fair value
$149.29−0.74 (-0.49%)
Close on Nov 12, 2026Market cap $10.35BP/E 24.3Yield –
Insulet pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Insulet's pe ratio was 28.0× on Nov 11, 2026, against 95.7× a year earlier. Over the last 5 years it ranged from 24.4× to 999.8×, with a median of 94.7×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 28.0× | −55.1 |
| 2025 | Dec 31, 2025 | 83.1× | +36.7 |
| 2024 | Dec 31, 2024 | 46.4× | −80.5 |
| 2023 | Dec 29, 2023 | 126.9× | −412.3 |
| 2022 | Oct 31, 2022 | 539.2× | −68.0 |
| 2021 | Jan 29, 2021 | 607.2× | +26.3 |
| 2020 | Dec 31, 2020 | 581.0× | −77.5 |
| 2019 | Dec 31, 2019 | 658.5× | – |
See a number that looks wrong?